Psilocybin and ibogaine are two of the most prominent psychoactive compounds used in spiritual, therapeutic, and research contexts. While their potential benefits—including mental health improvements, neuroplasticity, and addiction treatment—are increasingly recognized, legal restrictions vary significantly across countries. For individuals in the UK and Europe, understanding the regulatory landscape is essential to safely access these substances, […]